ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours

Activation of the ERK1/2 pathway is involved in malignant transformation both in vitro and in vivo. Little is known about the role of activated ERK1/2 in non-small cell lung cancer (NSCLC). The purpose of this study was to characterise the extent of the activation of ERK1/2 by immunohistochemistry i...

Descripción completa

Detalles Bibliográficos
Autores principales: Vicent, S, López-Picazo, J M, Toledo, G, Lozano, M D, Torre, W, Garcia-Corchón, C, Quero, C, Soria, J-C, Martín-Algarra, S, Manzano, R G, Montuenga, L M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Molecular and Cellular Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409626/
https://www.ncbi.nlm.nih.gov/pubmed/14997206
http://dx.doi.org/10.1038/sj.bjc.6601644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409626/
https://www.ncbi.nlm.nih.gov/pubmed/14997206
http://dx.doi.org/10.1038/sj.bjc.6601644

Ejemplares similares